Get the Stockscreener App
0.00
100.00%
-0.765
Genetic Technologies Ltd Adr Stock (GENE) Forecast
The Genetic Technologies Ltd Adr (GENE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.9323, representing a + increase from the current price of $0.00. The highest analyst price target is $0.8623, and the lowest is $1.0023.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GENE Price Target
Average 3.8577
(+ Upside)
Is Genetic Technologies Ltd Adr (GENE) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 9.04 | Buy |
| STOCH(9,6) | 49.19 | Neutral |
| STOCHRSI(14) | 77.72 | Neutral |
| MACD(12,26) | -0.0804 | Sell |
| ADX(14) | 45.13 | Sell |
| William %R | -100.00 | Buy |
| CCI(14) | -586.95 | Sell |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.6705
Sell
|
0.6183
Sell
|
| MA20 |
0.7197
Sell
|
0.6944
Sell
|
| MA50 |
0.7957
Sell
|
0.8254
Sell
|
| MA100 |
1.0649
Sell
|
1.0739
Sell
|
| MA200 |
1.7261
Sell
|
1.2263
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, GENE could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 13 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on GENE, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 9.04 indicates that GENE is oversold. This indicates that GENE price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 49.19 indicates that GENE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 77.72 indicates that GENE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 45.13 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -586.95 indicates that GENE is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term GENE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Genetic Technologies Ltd Adr financial reports and earnings history, Genetic Technologies Ltd Adr (GENE) stock could reach $3.7108 by 2030, $4.1044 by 2040 and $8.7238 by 2050. See the projected annual prices until 2050 of the Genetic Technologies Ltd Adr stock below:
- Genetic Technologies Ltd Adr (GENE) is expected to reach an average price of $2.3466 in 2035, with a high prediction of $2.3858 and a low estimate of $2.3466. This indicates an $ rise from the last recorded price of $0.00.
- Genetic Technologies Ltd Adr (GENE) stock is projected to chart a bullish course in 2040, with an average price target of $4.2205, representing an $ surge from its current level. The forecast ranges from a conservative $4.136 to a sky-high $4.1044.
- Our analysts predict Genetic Technologies Ltd Adr (GENE) to jump by 2045, soaring from $6.376 to an average price of $6.5422, potentially reaching $6.4823. While $6.376 is the low estimate, the potential upside is significant.
- Genetic Technologies Ltd Adr (GENE) stock is expected to climb by 2050, reaching an average of $8.6449, a $ jump from its current level. However, a wide range of estimates exists, with high and low targets of $8.7238 and $8.8245, respectively, highlighting the market's uncertainty.
Genetic Technologies Ltd Adr Stock (GENE) Year by Year Forecast
Genetic Technologies Ltd Adr Stock (GENE) Price Forecast for 2025
Genetic Technologies Ltd Adr Stock (GENE) is expected to reach an average price of $3.8577 in 2025, with a high prediction of $7.5646 and a low estimate of $0.1508. This indicates an + rise from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.9762 | $1.0023 | $0.8623 | + |
| February, 2025 | $1.0084 | $0.8984 | $2.44 | + |
| March, 2025 | $0.087 | $0.277 | $1.1446 | + |
| April, 2025 | $0.8762 | $0.1508 | $0.8562 | + |
| May, 2025 | $1.0016 | $1.0716 | $1.0739 | + |
| June, 2025 | $0.357 | $0.787 | $0.8654 | + |
| July, 2025 | $0.6762 | $0.5408 | $0.6685 | + |
| August, 2025 | $0.3916 | $0.5316 | $0.4801 | + |
| September, 2025 | $1.363 | $0.5454 | $7.5646 | + |
| October, 2025 | $0.8438 | $0.4338 | $1.9515 | + |
| November, 2025 | $0.7984 | $0.4422 | $1.3761 | + |
| December, 2025 | $0.2892 | $0.2392 | $1.1145 | + |
Genetic Technologies Ltd Adr Stock (GENE) Price Forecast for 2026
The predicted value for Genetic Technologies Ltd Adr (GENE) in 2026 is set at an average of $2.8903. Estimates vary from a peak of $5.6291 to a trough of $0.1515, indicating an + surge from the present price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.5738 | $0.1515 | $0.6615 | + |
| February, 2026 | $0.8084 | $0.4561 | $2.6522 | + |
| March, 2026 | $1.613 | $0.7545 | $2.383 | + |
| April, 2026 | $2.8138 | $1.5691 | $5.6291 | + |
| May, 2026 | $2.1284 | $1.0661 | $3.0499 | + |
| June, 2026 | $2.093 | $1.3545 | $3.263 | + |
| July, 2026 | $1.1637 | $1.0737 | $2.2214 | + |
| August, 2026 | $2.1184 | $1.1199 | $2.7584 | + |
| September, 2026 | $1.4891 | $1.2791 | $2.1868 | + |
| October, 2026 | $1.0137 | $0.9338 | $1.7176 | + |
| November, 2026 | $1.0484 | $0.5467 | $1.1284 | + |
| December, 2026 | $0.7691 | $0.7591 | $1.2445 | + |
Genetic Technologies Ltd Adr Stock (GENE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Genetic Technologies Ltd Adr (GENE) is $0.4835, with a high forecast of $0.9653 and a low forecast of $0.00166. This indicates an + increase from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.5837 | $0.4538 | $0.9653 | + |
| February, 2027 | $0.2183 | $0.00166 | $0.7599 | + |
| March, 2027 | $0.2009 | $0.0723 | $0.613 | + |
| April, 2027 | $0.3463 | $0.2947 | $0.2463 | + |
| May, 2027 | $0.3232 | $0.3101 | $0.2878 | + |
| June, 2027 | $0.2009 | $0.2209 | $0.0832 | + |
| July, 2027 | $0.1563 | $0.1824 | $0.1448 | + |
| August, 2027 | $0.4017 | $0.1801 | $0.2172 | + |
| September, 2027 | $0.8009 | $0.5455 | $0.7471 | + |
| October, 2027 | $0.8654 | $0.8386 | $0.7825 | + |
| November, 2027 | $0.6617 | $0.8271 | $0.8169 | + |
| December, 2027 | $0.3109 | $0.5109 | $0.4994 | + |
Genetic Technologies Ltd Adr Stock (GENE) Price Forecast for 2028
In 2028, Genetic Technologies Ltd Adr (GENE) is projected to reach an average price of $0.6173, with a high projection of $0.8683 and a low estimate of $0.3663. This indicates an + rise from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.5763 | $0.4848 | $0.4625 | + |
| February, 2028 | $0.7738 | $0.514 | $0.6217 | + |
| March, 2028 | $0.7159 | $0.7309 | $0.7111 | + |
| April, 2028 | $0.7463 | $0.7448 | $0.6934 | + |
| May, 2028 | $0.8556 | $0.7733 | $0.7289 | + |
| June, 2028 | $0.8409 | $0.8608 | $0.8683 | + |
| July, 2028 | $0.1863 | $0.3663 | $0.8526 | + |
| August, 2028 | $0.6656 | $0.4802 | $0.478 | + |
| September, 2028 | $0.661 | $0.6671 | $0.6233 | + |
| October, 2028 | $0.796 | $0.6587 | $0.7163 | + |
| November, 2028 | $0.7437 | $0.7579 | $0.727 | + |
| December, 2028 | $0.8402 | $0.7413 | $0.781 | + |
Genetic Technologies Ltd Adr Stock (GENE) Price Forecast for 2029
The 2029 price forecast for Genetic Technologies Ltd Adr Stock (GENE) is $1.2752 on average, with a high prediction of $2.2082 and a low estimate of $0.3422. This represents an + increase from the previous price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.8002 | $0.7525 | $0.7937 | + |
| February, 2029 | $0.8961 | $0.867 | $0.8912 | + |
| March, 2029 | $0.7235 | $0.8032 | $0.8094 | + |
| April, 2029 | $0.8887 | $0.7841 | $0.8164 | + |
| May, 2029 | $0.8306 | $0.8518 | $0.8379 | + |
| June, 2029 | $0.826 | $0.8233 | $0.7815 | + |
| July, 2029 | $0.9136 | $0.6261 | $1.6813 | + |
| August, 2029 | $0.4944 | $0.3422 | $1.3199 | + |
| September, 2029 | $0.5224 | $0.3876 | $0.669 | + |
| October, 2029 | $1.2698 | $0.3751 | $1.5564 | + |
| November, 2029 | $0.9444 | $0.7544 | $2.2082 | + |
| December, 2029 | $0.80 | $0.7305 | $1.0876 | + |
Genetic Technologies Ltd Adr Stock (GENE) Price Forecast for 2030
Genetic Technologies Ltd Adr Stock (GENE) is expected to reach an average price of $3.0147 in 2030, with a high forecast of $4.0385 and a low forecast of $1.9909. This signifies an + surge from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.6185 | $2.3077 | $3.7108 | + |
| February, 2030 | $3.6892 | $3.7692 | $3.6739 | + |
| March, 2030 | $3.80 | $3.6923 | $3.60 | + |
| April, 2030 | $4.1608 | $4.0277 | $3.8954 | + |
| May, 2030 | $4.1493 | $4.1116 | $4.0385 | + |
| June, 2030 | $3.79 | $3.94 | $4.0347 | + |
| July, 2030 | $3.9585 | $4.0254 | $3.9454 | + |
| August, 2030 | $4.0293 | $4.0393 | $3.9539 | + |
| September, 2030 | $1.7301 | $3.8901 | $3.7947 | + |
| October, 2030 | $2.0785 | $1.9909 | $1.9485 | + |
| November, 2030 | $3.7293 | $2.2162 | $2.8493 | + |
| December, 2030 | $4.2301 | $3.8124 | $3.7024 | + |
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):